Prognosis
WHO’s Hydroxychloroquine Trial Suspended Pending Safety Data
This article is for subscribers only.
The World Health Organization temporarily halted tests on hydroxychloroquine in its Covid-19 drug trials pending more data because of safety concerns.
The steering committee decided to suspend enrollment to that arm of the so-called Solidarity trials, WHO officials said Monday. That’s after the Lancet published a study that said the drug, touted by U.S. President Donald Trump as a treatment, was linked to an increased risk of death and heart ailments.